A Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Generalized Refractory Myasthenia Gravis (GMG)
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
January 15, 2014
End Date
June 30, 2017
Administered By
Neurology, Neuromuscular Disease
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
January 15, 2014
End Date
June 30, 2017